Litcius/Paper detail

Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute’s International Cell Therapy Committee

Takeshi Watanabe, Shin La Shu, Alberto Del Río-Espínola, Joana R. Ferreira, Kiyoko Bando, Myriam Lemmens, Parimal Pande, Charlotte de Wolf, Connie L. Chen, Ericson Elke, Gautham K. Rao, Tineke van den Hoorn, Lucilia Pereira Mouriès, Meagan B. Myers, Satoshi Yasuda

2025Cytotherapy18 citationsDOIOpen Access PDF

Topics & Concepts

Induced pluripotent stem cellRegenerative medicineCell therapyTeratomaIn vitro toxicologyBiologyBiotechnologyComputational biologyBioinformaticsStem cellIn vivoRisk analysis (engineering)MedicineEmbryonic stem cellPathologyCell biologyBiochemistryGenePluripotent Stem Cells ResearchCRISPR and Genetic EngineeringRenal and related cancers
Evaluating teratoma formation risk of pluripotent stem cell-derived cell therapy products: a consensus recommendation from the Health and Environmental Sciences Institute’s International Cell Therapy Committee | Litcius